Frontiers in Cardiovascular Medicine

DECEMBER 18, 2024

Despite improvements in clinical outcomes of acute myocardial infarction (AMI), mortality rates remain high, indicating the need for further understanding of the pathogenesis and developing more effective cardiac protection strategies.

Myocardial Infarction 52

Myocardial Infarction Physiology Biomarkers Innovation 52

Frontiers in Cardiovascular Medicine

FEBRUARY 18, 2025

However, studies on diagnostic markers related to cellular senescence in acute myocardial infarction (AMI) have not been reported. IntroductionCellular senescence can cause heart failure.

Myocardial Infarction 52

Myocardial Infarction Heart Failure Research 52

Open Heart

MARCH 25, 2025

We aimed to determine the risk of myocardial infarction (MI) and stroke after BSI. Background Cardiovascular disease (CVD) events triggered by inflammation are an underappreciated and poorly quantified cause of morbidity and mortality in patients with bloodstream infections (BSIs).

Myocardial Infarction 52

Myocardial Infarction Strokes Stroke Cardiovascular Disease 52

Frontiers in Cardiovascular Medicine

FEBRUARY 6, 2025

Cardiovascular diseases are the most lethal diseases worldwide, of which myocardial infarction is the leading cause of death.

Myocardial Infarction 52

Myocardial Infarction Cardiovascular Disease Research 52

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2025

The main content of this paper is to explore the application of stem cells and gene technology in the treatment of myocardial infarction (MI). It has become an urgent task for clinical medicine to seek new and better treatment.

Myocardial Infarction 52

Myocardial Infarction Quality of Life Heart Transplant Ischemia 52

Heart BMJ

MARCH 26, 2025

Heart failure (HF) is one of the significant complications in patients with myocardial infarction (MI), leading to increased risk for cardiovascular morbidity and mortality. 2 However, mortality rate is greater in HF cases developing >3 days following MI compared with less than or equal to 3 days after MI.

Myocardial Infarction 52

Myocardial Infarction Preserved Ejection Fraction Heart Failure Aortic valve 52

Cardiology Update

JUNE 16, 2024

However, the association between vessel-level coronary atherosclerotic plaque activity and the incidence of vessel-level myocardial infarction (MI) has not been fully explored. This included an elevated risk of cardiac death or myocardial infarction (HR: 2.43; 95% CI: 1.37-4.30; 4.39; P = 0.002) myocardial infarctions.

Myocardial Infarction 98

Myocardial Infarction Plaque Coronary Artery Disease Research 98

Frontiers in Cardiovascular Medicine

JANUARY 23, 2025

Background Early prediction of heart failure (HF) after acute myocardial infarction (AMI) is essential for personalized treatment.

Myocardial Infarction 52

Myocardial Infarction Heart Failure Research Hospital 52

Dr. Smith's ECG Blog

DECEMBER 11, 2023

Occlusion myocardial infarction is a clinical diagnosis Written by Willy Frick (@Willyhfrick). St depression in lead AVL differentiates inferior st-elevation myocardial infarction from pericarditis. link] Opiates are associated with worse outcomes in Myocardial Infarction. Circulation , 130 (25). Worrall, C.,

Myocardial Infarction 123

Myocardial Infarction Chest Pain STEMI Blood Pressure 123

JAMA Cardiology

AUGUST 6, 2024

This secondary analysis of the Valsartan in Acute Myocardial Infarction (VALIANT) and Prospective ARNi vs ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI (PARADISE-MI) randomized clinical trials investigates the changes over time in sudden death rate after myocardial infarction and the characteristics of people (..)

Myocardial Infarction 95

Myocardial Infarction ACE Inhibitor Heart Failure 95

Open Heart

JANUARY 21, 2025

Background Atrial fibrillation (AF) and acute myocardial infarction (AMI) share risk factors and are bidirectionally associated. Several studies found higher risks of outcomes in individuals with both conditions. Whether the risks of outcomes differ according to temporal order of AF and AMI is unclear.

Myocardial Infarction 52

Myocardial Infarction Atrial Fibrillation Diet Cancer 52

Frontiers in Cardiovascular Medicine

FEBRUARY 24, 2025

ObjectiveThis study aimed to evaluate the correlation between aerobic exercise intensity based on the 6min walk test (6MWT) and the anaerobic threshold (AT)-based equivalent in patients with acute myocardial infarction (AMI).

Myocardial Infarction 52

Myocardial Infarction Exercise Hospital Research 52

Cardiovascular Diabetology

JANUARY 3, 2025

Yet, the impact of GLP-1RA treatment before ST-segment elevation myocardial infarction (STEMI) on. Glucagon-like peptide-1 receptor agonist (GLP-1RA) treatment reduces cardiovascular events in type 2 diabetes.

Myocardial Infarction 115

Myocardial Infarction Diabetes STEMI Research 115

Frontiers in Cardiovascular Medicine

DECEMBER 3, 2024

However, whether immediate blood glucose and FIB levels affect coronary blood flow during primary percutaneous coronary intervention (PCI) remains unclear.ObjectiveTo explore the correlation between admission blood glucose (ABG), fibrinogen (FIB) and slow blood flow during primary PCI for acute ST segment elevation myocardial infarction (STEMI).MethodsA

Myocardial Infarction 52

Myocardial Infarction STEMI Risk Factors Hospital 52

Open Heart

FEBRUARY 17, 2025

Background Despite limited beneficial evidence, mechanical circulatory support (MCS) is commonly used in patients with acute myocardial infarction-related cardiogenic shock (AMI-CS). In this Dutch registry, we investigated MCS usage, associated patient characteristics and clinical outcomes.

Cardiogenic Shock 52

Cardiogenic Shock Myocardial Infarction Aortic Outcomes 52

Heart BMJ

SEPTEMBER 25, 2024

In the beginning of the 20th century, the first reports of the clinical manifestations of myocardial infarction (MI) appeared, followed around a decade later by reports regarding the electrocardiographic (ECG) changes associated with MI ( figure 1 ).

Myocardial Infarction 98

Myocardial Infarction Document 98

The New England Journal of Medicine

FEBRUARY 12, 2025

In a randomized trial involving patients with acute myocardial infarction, colchicine did not decrease the risk of major adverse cardiovascular events over a median follow-up period of 3 years.

Myocardial Infarction 71

Myocardial Infarction 71

DAIC

JULY 10, 2024

a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced success from a collaborative Phase II trial of ProtheraCytes for the treatment of acute myocardial infarction (AMI) led by CellProthera , as well as plans to continue the relationship into Phase III.

Myocardial Infarction 105

Myocardial Infarction Heart Failure Heart Attack Heart attacks 105

Frontiers in Cardiovascular Medicine

FEBRUARY 24, 2025

IntroductionAcute coronary syndrome refers to a group of diseases characterized by sudden, decreased blood supply to the heart muscle that results in cell death, also known as acute myocardial infarction. The majority of patients (67.9%) have been diagnosed with ST- Elevated Myocardial Infarction and were classified as Killip class I.

Hospital 98

Hospital Myocardial Infarction Chest Pain Electrocardiogram 98

HeartRhythm

DECEMBER 31, 2024

Curtain etal1 performed an analysis of the VALIANT (Valsartan in Acute Myocardial Infarction) and PARADISE-MI (Prospective ARNi vs ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI) trials to evaluate whether risk of sudden cardiac arrest (SCA) following acute myocardial infarction (MI) has changed over time.

Cardiac Arrest 79

Cardiac Arrest ACE Inhibitor Myocardial Infarction Heart Failure 79

Circulation

FEBRUARY 13, 2025

The development of coronary care units is often credited for a dramatic decline in mortality rates after acute myocardial infarction throughout the 1960s. As the underlying patient population became progressively sicker, changes in organizational structure, staffing, care delivery, and training paradigms lagged.

Critical Care 72

Critical Care Myocardial Infarction Research Cardiovascular Disease 72

American College of Cardiology

OCTOBER 29, 2024

The goal of the CLEAR SYNERGY OASIS 9 trial was to determine the long-term cardiovascular (CV) effects of colchicine following percutaneous coronary intervention (PCI) for ST-segment elevation or large non–ST-segment elevation myocardial infarction (STEMI or NSTEMI, respectively).

Myocardial Infarction 68

Myocardial Infarction STEMI Article 68

Open Heart

JANUARY 17, 2024

Objective In the COVERT-MI randomised placebo-controlled trial, oral administration of high-dose colchicine at the time of reperfusion and for 5 days in acute ST-elevated myocardial infarction did not reduce infarct size but was associated with a significant increase in left ventricular thrombus (LVT) in comparison to placebo.

Myocardial Infarction 96

Myocardial Infarction Quality of Life Heart Failure Strokes 96

Frontiers in Cardiovascular Medicine

DECEMBER 9, 2024

BackgroundMyocardial infarction(MI) is one of the most serious health threats.

Myocardial Infarction 52

Myocardial Infarction Research 52

JAMA Cardiology

JUNE 17, 2024

This genetic association study evaluated genetic variants associated with increased risk of vasospastic angina.

Angina 108

Angina Myocardial Infarction 108

HCPLive

APRIL 12, 2024

Ankeet Bhatt, MD, MBA, discusses a NUDGE-FLU analysis from ACC.24 24 examining effect of the CV gain-framed nudge in patients with and without history of AMI.

Myocardial Infarction 119

Myocardial Infarction 119

The New England Journal of Medicine

MARCH 26, 2025

This feature about a man who had had a myocardial infarction with preserved left ventricular ejection fraction offers a case vignette accompanied by two essays, one supporting the use of beta-blockers after discharge and the other recommending no use of beta-blockers.

Myocardial Infarction 56

Myocardial Infarction 56

Open Heart

MARCH 28, 2025

The presence of atrial arrhythmias during stress testing at all time points was also associated with later diagnosis of coronary artery disease or myocardial infarction: OR 1.82 (95% CI 1.09, 3.03), p=0.02. However, it is linked to subsequent diagnosis of AF, coronary artery disease and myocardial infarction.

Arrhythmia 52

Arrhythmia Coronary Artery Disease Myocardial Infarction Atrial Fibrillation 52

Cardiovascular Diabetology

MAY 26, 2024

Stress hyperglycemia, which is associated with poor prognosis in patients with acute myocardial infarction (AMI), can be determined using the stress hyperglycemia ratio (SHR). Impaired left ventricular functio.

Myocardial Infarction 78

Myocardial Infarction Research 78

Cardiovascular Diabetology

JANUARY 17, 2025

The aim of this study was to investigate the difference between perceived and calculated diabetes risks among post-myocardial infarction (AMI) patients using the Finnish Diabetes Risk Score (FINDRISC).

Myocardial Infarction 64

Myocardial Infarction Diabetes Research 64

Med Page Today

JUNE 26, 2024

(MedPage Today) -- Influenza infection was associated with an increased risk of acute myocardial infarction (MI), especially for those without a prior hospitalization for coronary artery disease (CAD), according to a Dutch observational case series.

Heart Attack 143

Heart Attack Heart attacks Coronary Artery Disease Myocardial Infarction 143

JAMA Cardiology

SEPTEMBER 1, 2024

This post hoc analysis of a randomized clinical trial analyzes imaging data for atheroma volume at the lesion level from patients who received intensive lipid-lowering therapy with alirocumab plus statin compared with a statin alone.

Myocardial Infarction 102

Myocardial Infarction 102

Frontiers in Cardiovascular Medicine

NOVEMBER 17, 2024

Multiple logistic regression and restricted cubic spline (RCS) analyses were conducted to assess both linear and nonlinear associations between WWI and myocardial infarction. Subgroup analyses and interaction tests were also performed.ResultsAmong the 31,535 participants analyzed, 1,449 (4.82%) had experienced a myocardial infarction.

Myocardial Infarction 59

Myocardial Infarction BMI Angina Obesity 59

Frontiers in Cardiovascular Medicine

MARCH 28, 2025

ST-elevation myocardial infarction (STEMI) is a critical cardiovascular emergency characterized by acute coronary artery occlusion and subsequent myocardial injury. The current standard of care is primary percutaneous coronary intervention (PPCI), which aims to rapidly restore epicardial blood flow.

Thrombolysis 52

Thrombolysis STEMI Myocardial Infarction Article 52

Cardiovascular Diabetology

JANUARY 21, 2025

The impact of sodiumglucose cotransporter-2 (SGLT2) inhibitors on mortality following myocardial infarction (MI) remains uncertain. Additionally, the role of type 2 diabetes mellitus (T2DM) and heart failure.

Myocardial Infarction 64

Myocardial Infarction Heart Failure Diabetes Research 64

Open Heart

MARCH 28, 2025

Background High-sensitivity cardiac troponin tests have enhanced early myocardial infarction diagnosis, yet many patients still land in the observe zone (OZ). The prevalence of non-ST-segment elevation myocardial infarction (NSTEMI) within the OZ was 7.2%. Results Of the 4605 patients, 948 were triaged to the OZ (20.6%).

Myocardial Infarction 52

Myocardial Infarction Outcomes 52

Journal of Cardiothoracic Surgery

MARCH 24, 2025

The objective was to assess the clinical efficacy of long non-coding RNA (lncRNA) alpha-2-macroglobulin-antisense 1 (A2M-AS1) in acute myocardial infarction (AMI).

Myocardial Infarction 52

Myocardial Infarction Research 52